ONCOLOGY

The value of a postoperative nomogram based on the primary tumor score for overall survival of patients with renal cell carcinoma and inferior vena cava tumor thrombus

May 11, 2025 by in ONCOLOGY Comments Off on The value of a postoperative nomogram based on the primary tumor score for overall survival of patients with renal cell carcinoma and inferior vena cava tumor thrombus

Highlights • Regarding the controversy over the prognostic value of the primary tumor, our study supports that the level of IVCTT and tumor size have no significant prognostic value. •…

read more

Gene expression of prostate-specific membrane antigen ( FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors

May 11, 2025 by in ONCOLOGY Comments Off on Gene expression of prostate-specific membrane antigen ( FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors

Highlights • Combination systemic therapies (STs) including immuno-oncologic (IO) and VEGF-inhibiting (VEGFi) agents, predominantly tyrosine kinase inhibitors (TKI), have become the standard of care for metastatic clear cell carcinoma. •…

read more

The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis

May 11, 2025 by in ONCOLOGY Comments Off on The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis

Highlights • Intravesical chemotherapy significantly reduces intravesical recurrence risk after NUT at 12 (OR 0.46) and 24 months (OR 0.41). • No statistically significant difference was found between single intra…

read more

Assessing the causal relationship between gut microbiota and prostate cancer: A two-sample Mendelian randomization study

May 11, 2025 by in ONCOLOGY Comments Off on Assessing the causal relationship between gut microbiota and prostate cancer: A two-sample Mendelian randomization study

Highlights • Identified 12 gut microbial taxa potentially linked to prostate cancer risk using MR analysis. • Employed robust statistical methods to ensure reliability of causal inference results. • Explored…

read more

Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States

May 11, 2025 by in ONCOLOGY Comments Off on Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States

Highlights • Real-world study of US adults with la/mUC receiving first-line therapy. • Most received platinum-based chemotherapy (48.2%) or PD-1/L1 inhibitor (35.5%). • All first-line therapies had short survival, high…

read more

Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211

May 11, 2025 by in ONCOLOGY Comments Off on Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211

Highlights • In preclinical studies, it has been demonstrated that antihistamines may reverse macrophage immunosuppression, reactivate t-cell cytotoxicity, and enhance the immunotherapy response. • By use of individual patient data…

read more
Get Clinical Tree app for offline access